Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations

被引:9
作者
Marchi, Rita [1 ,2 ]
Vilar, Rui [3 ]
Durual, Stephane [4 ]
Goodyer, Matthew [5 ]
Gay, Valerie [6 ]
Neerman-Arbez, Marguerite [3 ]
Casini, Alessandro [2 ,7 ]
机构
[1] Inst Venezolano Invest Cient, Expt Med, Caracas, Venezuela
[2] Univ Geneva, Fac Med, Geneva, Switzerland
[3] Univ Geneva, Dept Genet Med & Dev, Fac Med, Geneva, Switzerland
[4] Univ Geneva, Univ Clin Dent Med, Biomat Lab, Geneva, Switzerland
[5] Inst Cent Hop, Serv Hematol, Hop Valais, Sion, Switzerland
[6] Ctr Hosp Metropole Savoie, Hemophilia Treatment Ctr, Chambery, France
[7] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland
关键词
Hypodysfibrinogenemia; Clot structure; Laser scanning confocal microscopy; Scanning electron microscopy; Fibrinogen; Frameshift mutation; Missense mutation; ALPHA-CHAIN; FACTOR-XIII; POLYMERIZATION; IDENTIFICATION; MECHANISMS;
D O I
10.1016/j.thromres.2020.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital hypodysfibrinogenemia is a rare fibrinogen disorder, defined by decreased levels of a dysfunctional fibrinogen. We present the functional and structural characterization of two new fibrinogen variants. A duplication of 32 bases in FGA exon 5, p.Ser382GlyfsTer50 was identified in a patient (P1) with history of hemoptysis and traumatic cerebral bleeding. A missense mutation in FGG exon 8, p.Ala353Ser was identified in two siblings (P2 and P3) with tendency to bruising and menorrhagia. Fibrin polymerization was studied in plasma and in purified fibrinogen by turbidimetry. Fibrin structure was studied by a permeability assay, laser scanning confocal microscopy (LSCM) and scanning electron microscopy (SEM). In both plasma and purified fibrinogen samples, all patients had an abnormal polymerization characterized by a decreased maximal absorption compared to controls. The permeation constant (Ks) was markedly increased in all patients: 31 +/- 9 x 10(-9) cm(2) in P1, and 20 +/- 0.1 x 10(-9) cm(2) in P2 and P3, compared to 6 +/- 2 x 10(-9) cm(2) in the control (p < 0.05). The presence of very large pores that accounts for the increased Ks was confirmed by LSCM and SEM patients' clots images. By SEM, the patients' fibrin fibers diameters were thicker: 90 +/- 25 nm in P1, 162 +/- 64 nm in P2 and 132 +/- 46 nm in P3 compared to 74 +/- 25 nm in control (p < 0.0001). In conclusion, both new causative fibrinogen mutations altered clot structure by forming thick fibers, diminishing fiber branching, and increasing pore filling space. These structural changes to clots explain the patients' bleeding phenotypes.
引用
收藏
页码:56 / 64
页数:9
相关论文
共 40 条
  • [1] Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization
    Amri, Y.
    Jouini, H.
    Becheur, M.
    Dabboubi, R.
    Mahjoub, B.
    Messaoud, T.
    Sfar, M. T.
    Casini, A.
    de Moerloose, P.
    Toumi, N. E. H.
    [J]. HAEMOPHILIA, 2017, 23 (04) : E340 - E347
  • [2] Novel fibrinogen (Bβ401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid content
    Brennan, Stephen O.
    Roncolato, Fernando
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) : 551 - 553
  • [3] Deletion of five residues from the coiled coil of fibrinogen (Bβ Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia
    Brennan, Stephen O.
    Davis, Ryan L.
    Lowen, Robin
    Ruskova, Anna
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (04): : 585 - 588
  • [4] Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH
    Casini, A.
    Undas, A.
    Palla, R.
    Thachil, J.
    De Moerloose, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (09) : 1887 - 1890
  • [5] Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation
    Casini, A.
    Brungs, T.
    Lavenu-Bombled, C.
    Vilar, R.
    Neerman-Arbez, M.
    de Moerloose, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 876 - 888
  • [6] Natural history of patients with congenital dysfibrinogenemia
    Casini, Alessandro
    Blondon, Marc
    Lebreton, Aurelien
    Koegel, Jeremie
    Tintillier, Veronique
    de Maistre, Emmanuel
    Gautier, Philippe
    Biron, Christine
    Neerman-Arbez, Marguerite
    de Moerloose, Philippe
    [J]. BLOOD, 2015, 125 (03) : 553 - 561
  • [7] AMINO-ACID SEQUENCE STUDIES ON THE ALPHA-CHAIN OF HUMAN-FIBRINOGEN - EXACT LOCATION OF CROSS-LINKING ACCEPTOR SITES
    COTTRELL, BA
    STRONG, DD
    WATT, KWK
    DOOLITTLE, RF
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5405 - 5410
  • [8] de Lange Z, 2012, J THROMB HAEMOST, V10, pE1
  • [9] Congenital Fibrinogen Disorders: An Update
    de Moerloose, Philippe
    Casini, Alessandro
    Neerman-Arbez, Marguerite
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (06) : 585 - 595
  • [10] Crystal structure of fragment double-D from human fibrin with two different bound ligands
    Everse, SJ
    Spraggon, G
    Veerapandian, L
    Riley, M
    Doolittle, RF
    [J]. BIOCHEMISTRY, 1998, 37 (24) : 8637 - 8642